← All comparisons
Head-to-head · FAERS comparison

Pregabalin vs Carbamazepine: side effects in FDA adverse event reports

How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

PregabalinCarbamazepine
Drug class–Mood Stabilizer
Brand names––
FAERS reports270,52566,609
Serious67%86%
Death outcome22,0805,605
Boxed warningNoYes SERIOUS DERMATOLOGIC REACTIONS AND HLA-B*1502 ALLELE SERIOUS AND SOMETIMES FATAL DERMATOLOGIC REACTIONS, INCLUDING TOXIC EPIDERMAL NECROLYSIS (TEN) AND STEVENS-

Signals both drugs share

No strong shared signal after removing coding and lab terms.

Labeled signals distinctive to Pregabalin

Labeled signals distinctive to Carbamazepine

Common questions

Which has more reported side effects, Pregabalin or Carbamazepine?

Pregabalin has 270,525 FAERS reports and Carbamazepine 66,609. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (67% vs 86%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Pregabalin and Carbamazepine share?

They share no strong flagged signal after artifacts and lab terms are removed.

Is Pregabalin or Carbamazepine safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.